AstraZeneca Surpasses Q3 Expectations with Robust Revenue Growth ...Middle East

AstraZeneca has delivered an impressive financial performance in the third quarter of 2024, surpassing market expectations. The pharmaceutical giant reported a core EPS of $2.08, eclipsing the IBES estimate of $2.01, and total revenue of $13,565 million, which exceeded the forecasted $13,046 million.

Hence then, the article about astrazeneca surpasses q3 expectations with robust revenue growth was published today ( Tuesday 12/11/2024 - 10:25 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca Surpasses Q3 Expectations with Robust Revenue Growth )

Also on site :

• Grammy Showdown: Bad Bunny, Kendrick Lamar, Lady Gaga Vie for Top Honors
• India's Growth Surge: Aiming for 7.5% GDP with Reforms
• NYC Council’s Safe Access bills ensure New Yorkers can passionately protest — without being scared to worship